<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=489233&amp;fmt=gif">
Search

    The Cost of Inaction: what delaying quality modernization is really costing you

    Don't let your quality system's modernization be pushed back.

    Agenda

    11:10
    The Cost of Fragmented Systems

    17:45
    Data Integrity and traceability

    34:10
    Why organizations delay

    37:50
    Making the right choice

    42:55
    The real Cost of Inaction

    45:00
    Q&A

    Although many pharmaceutical organizations recognize the value of modernizing their quality systems, the decision to act is often deprioritized. But at what cost? In this session, Lesley Worthington, Communication and Leadership Coach, and Angel Buendía, Scilife’s Knowledge Manager will explore where the cost of inaction shows up across daily operations and leadership decisions, and why maintaining the status quo may carry more risk than expected.

     

    You’ll learn how to:

    • Where hidden costs appear in deviations, CAPAs, audit findings, and manual rework.

    • The operational strain on small or overloaded quality teams.

    • Data integrity and traceability risks in hybrid or paper-based systems

    • Why organizations delay digital transformation, even when gaps are visible.